课题基金 / 基金详情

INFECTIVITY OF HSIV-VIF CHIMERA IN PIGTAILED MACAQUES

INFECTIVITY OF HSIV-VIF CHIMERA IN PIGTAILED MACAQUES
HSIV-VIF 嵌合体在斑尾猕猴中的感染性
批准号:
8357599
负责人:
Shiu-Lok Hu
金额:
$37.79万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-05-01 至 2012-04-30

项目摘要

项目成果

Shiu-Lok Hu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Currently, there is no animal model for HIV-1 infection and disease because the virus is highly specific for humans. Macaques are generally resistant to HIV-1, with the exception being pig-tailed macaques. Our lab showed that pig-tailed macaques are unable to express functional isoforms of TRIM5-alpha, which has been identified as a host factor that restricts the replication of HIV-1 in rhesus monkeys. Therefore, it is possible that HIV-1 will only need to overcome restriction by another host factor, APOBEC3G/F, to replicate successfully in pig-tailed macaques. To test this hypothesis, we collaborated with Dr. J. Kimata of Baylor College of Medicine, who engineered an HIV-1 clone that includes the vif gene of SIVmne, allowing it to counteract APOBEC3G/F-mediated restriction. This chimeric virus, Pt-tropic HIV-1, is 96% HIV-1 and 4% SIV. It replicates in stimulated pig-tailed macaque blood cells as efficiently as SIVmne. In this pilot study, we inoculated 2 pig-tailed macaques intravenously with HSIV-vif. Both animals became infected and seroconverted, with plasma viremia detectable 1 wk after infection and reaching a peak between 104-105 copies/ml at wk 2.. Plasma viral load persisted for 10 months after infection between 102-103 copies/ml, but remained at baseline (d102 copies/ml) thereafter. To gain further insight on factors required for robust infection in pig-tailed macaques, we identified two notable differences between the Pt-tropic HIV-1 and SIVmne (1) SIV Vif does not associate with Pt-tropic HIV-1 viral particles; (2) while Pt-tropic HIV-1 degrades both Pt APOBEC3G and APOBEC3F, it prevents their inclusion in virions to a lesser extent than pathogenic SIVmne. Thus, while SIV Vif is necessary for persistent infection by Pt-tropic HIV-1, improved expression and inhibition of APOBEC3 proteins may be required for robust viral replication in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
VIRUS-LIKE PARTICLES WITH STABILIZED TRIMERIC ENVELOPE FOR PRIME BOOST IMMUNIZATION
  • 批准号:
    9530535
  • 项目类别:
  • 资助金额:
    $61.53万
  • 财政年份:
    2017
  • 负责人:
    Shiu-Lok Hu
  • 依托单位:
PROTECTIVE EFFICACY OF GLYCAN-MODIFIED ENV VACCINE
  • 批准号:
    8357597
  • 项目类别:
  • 资助金额:
    $37.79万
  • 财政年份:
    2011
  • 负责人:
    Shiu-Lok Hu
  • 依托单位:
Recombinant Protein Immunogens
  • 批准号:
    8327071
  • 项目类别:
  • 资助金额:
    $33.65万
  • 财政年份:
    2011
  • 负责人:
    Shiu-Lok Hu
  • 依托单位:
IMMUNOPATHOGENESIS OF CLADE C SHIV-1157IPD3N4 IN M NEMESTRINA
  • 批准号:
    8357596
  • 项目类别:
  • 资助金额:
    $37.79万
  • 财政年份:
    2011
  • 负责人:
    Shiu-Lok Hu
  • 依托单位:
海外基金